Avecho Biotechnology Ltd V.AVE

Primary Symbol: AVEFF

Healthcare Biotechnology

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ltd > Financials

<< Previous

Bullboard Posts

Next >>

Comment by eljoroon Mar 07, 2018 7:40pm

120 Views

Post# 27679613

RE:Financials

TMXmoney.com lists AVE releasing their next set of financials on Tuesday April 10th. If that date holds we will likely see an announcement from AVE management about timing details and any CC about 2 weeks before the 10th.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks